Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.495 USD | +0.41% | -8.15% | -6.18% |
May. 10 | Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M | MT |
Mar. 25 | Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.18% | 12.94M | |
+14.72% | 118B | |
+13.06% | 106B | |
-3.00% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-17.13% | 15.56B | |
+4.54% | 13.63B | |
+28.01% | 12.27B |
- Stock Market
- Equities
- KPRX Stock
- News Kiora Pharmaceuticals, Inc.
- HC Wainwright Raises Kiora Pharmaceuticals' Price Target to $7 From $6, Maintains Buy Rating